Ginseng Polysaccharides can enhance the sensitivity of tumor patients who are resistant to PD-1 inhibitors by improving the gut microbiota structure in non-small cell lung cancer patients and increasing the microbial metabolite pentanoate (87). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.